San Diego, CA, United States of America

Mallareddy Komandla


 

Average Co-Inventor Count = 8.6

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2004-2021

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Mallareddy Komandla

Introduction:

Mallareddy Komandla, a talented inventor based in San Diego, CA, has made significant contributions to the field of cardiac disease treatment through his innovative patented compounds.

Latest Patents:

Komandla's latest patents showcase his groundbreaking work in developing substituted amines for treating cardiac diseases. The compounds he has invented exhibit CaMKII inhibitory action and show promising potential as agents for the prophylaxis and treatment of various cardiac conditions like catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, and fatal arrhythmia.

Career Highlights:

With an impressive portfolio of 7 patents, Mallareddy Komandla has established himself as a leading figure in the medical innovation landscape. He has worked with renowned companies like Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals, LLC, where he has continued to drive forward cutting-edge research and development initiatives.

Collaborations:

Komandla has collaborated closely with esteemed professionals in the industry, including his coworkers John David Lawson and Joanne Miura. Through these collaborations, he has been able to leverage diverse expertise and insights to further enhance the efficacy and applicability of his patented inventions.

Conclusion:

In conclusion, Mallareddy Komandla's trailblazing work in developing novel compounds for the treatment of cardiac diseases underscores his commitment to advancing medical science and improving patient outcomes. His relentless pursuit of innovation serves as an inspiration to aspiring inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…